William Blair Equities Analysts Lower Earnings Estimates for Option Care Health, Inc. (NASDAQ:OPCH)

Option Care Health, Inc. (NASDAQ:OPCHGet Rating) – Stock analysts at William Blair lowered their Q2 2022 earnings per share estimates for Option Care Health in a research note issued to investors on Thursday, April 28th. William Blair analyst M. Larew now expects that the company will earn $0.27 per share for the quarter, down from their prior forecast of $0.37.

Several other research analysts also recently commented on OPCH. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Option Care Health from $32.00 to $39.00 in a report on Friday. Barrington Research raised their price target on shares of Option Care Health from $31.00 to $33.00 in a research report on Friday. Zacks Investment Research upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and set a $31.00 target price on the stock in a research report on Tuesday, April 26th. Finally, TheStreet lowered shares of Option Care Health from a “b” rating to a “c+” rating in a research report on Thursday. Six investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Option Care Health presently has an average rating of “Buy” and a consensus target price of $31.17.

Option Care Health stock opened at $29.88 on Monday. The company has a market cap of $5.39 billion, a P/E ratio of 31.13, a P/E/G ratio of 1.49 and a beta of 1.38. The firm’s fifty day simple moving average is $27.32. The company has a quick ratio of 1.15, a current ratio of 1.55 and a debt-to-equity ratio of 0.90. Option Care Health has a 1-year low of $16.02 and a 1-year high of $30.70.

Option Care Health (NASDAQ:OPCHGet Rating) last released its earnings results on Thursday, April 28th. The company reported $0.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.13 by $0.04. Option Care Health had a net margin of 4.81% and a return on equity of 12.85%. The company had revenue of $915.78 million during the quarter, compared to the consensus estimate of $839.45 million. During the same quarter in the prior year, the firm earned ($0.02) EPS. The company’s revenue was up 20.6% compared to the same quarter last year.

A number of hedge funds and other institutional investors have recently bought and sold shares of OPCH. Morgan Stanley raised its position in shares of Option Care Health by 63.6% in the second quarter. Morgan Stanley now owns 202,717 shares of the company’s stock valued at $4,434,000 after purchasing an additional 78,818 shares during the period. SG Americas Securities LLC grew its stake in Option Care Health by 4.1% during the third quarter. SG Americas Securities LLC now owns 20,124 shares of the company’s stock worth $488,000 after buying an additional 791 shares in the last quarter. Victory Capital Management Inc. grew its stake in Option Care Health by 100.9% during the third quarter. Victory Capital Management Inc. now owns 30,169 shares of the company’s stock worth $732,000 after buying an additional 15,151 shares in the last quarter. Raymond James & Associates acquired a new stake in Option Care Health during the third quarter worth about $248,000. Finally, Retirement Systems of Alabama acquired a new stake in shares of Option Care Health in the 3rd quarter valued at approximately $4,386,000. 97.80% of the stock is currently owned by hedge funds and other institutional investors.

In other news, COO Harriet Booker sold 6,000 shares of the company’s stock in a transaction that occurred on Monday, March 7th. The shares were sold at an average price of $26.12, for a total value of $156,720.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In the last 90 days, insiders have sold 18,000 shares of company stock valued at $461,460. Corporate insiders own 47.00% of the company’s stock.

About Option Care Health (Get Rating)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Featured Articles

Earnings History and Estimates for Option Care Health (NASDAQ:OPCH)

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.